Oculis Holding AG (OCS) Exchange Rate Effect (2022 - 2026)
Oculis Holding AG's (OCS) quarterly Exchange Rate Effect came in at $619347.3 in Q1 2026, up 146.48% year-on-year from $251275.9 in Q1 2025, and up 6287.68% quarter-over-quarter from -$10009.4 in Q4 2025.
Oculis Holding AG (OCS) Exchange Rate Effect (2022 - 2026) Analysis & Trends
Oculis Holding AG's Exchange Rate Effect history runs 5 years deep, the most recent figure standing at $619347.3 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 146.48% year-over-year to $619347.3 in Q1 2026; TTM through Mar 2026 was -$5.3 million, a 147.62% decrease from a year earlier, with the FY2025 full-year figure at -$7.3 million, down 1679.62% from the prior year.
- Exchange Rate Effect rose to $619347.3 in Q1 2026 per OCS's latest filing, from -$10009.4 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $4.7 million in Q3 2023 and bottomed at -$5.7 million in Q2 2025.
- The 5-year median for Exchange Rate Effect is -$327314.9 (2024), against an average of -$640262.8.
- Across the five-year window, Exchange Rate Effect soared 1878.16% in 2023 and tumbled 1653.63% in 2025, its largest moves.
- Year by year, Exchange Rate Effect stood at -$446349.4 in 2022, then sank by 291.23% to -$1.7 million in 2023, then jumped by 154.98% to $960019.9 in 2024, then tumbled by 101.04% to -$10009.4 in 2025, then soared by 6287.68% to $619347.3 in 2026.
- Per Business Quant, the three latest OCS Exchange Rate Effect figures stand at $619347.3 (Q1 2026), -$10009.4 (Q4 2025), and -$126261.1 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | -7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 619,347.27 |
| Mar 31, 2026 | 619,347.27 |
| Dec 31, 2025 | -10,009.36 |
| Dec 31, 2025 | -10,009.36 |
| Sep 30, 2025 | -126,261.06 |
| Sep 30, 2025 | -126,261.06 |
| Jun 30, 2025 | -5.74 Mn |
| Jun 30, 2025 | -5.74 Mn |
| Mar 31, 2025 | -1.33 Mn |
| Mar 31, 2025 | -1.33 Mn |
| Dec 31, 2024 | 960,019.87 |
| Dec 31, 2024 | 960,019.87 |
| Sep 30, 2024 | -1.42 Mn |
| Sep 30, 2024 | -1.42 Mn |
| Jun 30, 2024 | -327,314.87 |
| Jun 30, 2024 | -327,314.87 |
| Mar 31, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | -1.75 Mn |
| Dec 31, 2023 | -1.75 Mn |